Unüvar Tolga, Demir Korcan, Abacı Ayhan, Büyükgebiz Atilla, Böber Ece
Adnan Menderes University Faculty of Medicine, Main Department of Child Health and Illnesses, Department of Endocrinology, Aytepe Street, Aydın, Turkey. E-mail:
J Clin Res Pediatr Endocrinol. 2013 Sep 10;5(3):170-3. doi: 10.4274/Jcrpe.931.
Studies on the clinical course of children with hyperthyrotropinemia are scarce. We aimed to evaluate the role of presentation findings in such infants to predict eventual outcome.
Files of infants diagnosed as suspicious congenital hypothyroidism (CH) in the neonatal or early infancy period in the past ten years were analyzed retrospectively, and 37 patients (M/F: 20/17) with hyperthyrotropinemia diagnosed at a median age of 3.2 months were included in the study. Criteria for inclusion were: normal free thyroxine (fT4) levels and thyrotropin (TSH) levels between 10-20 μIU/mL during the initial neonatal screening (or TSH<10μIU/mL afterwards). Cases with permanent CH (Group 1) were compared to those with transient hyperthyrotropinemia (Group 2) regarding age at the time of diagnosis, sex, gestational age, birth weight, symptoms, ultrasonographic and scintigraphic findings, initial thyroid function tests, and state of mental and motor development.
Of the total group, 20 patients (54%) were eventually diagnosed as permanent CH. T4 doses that maintained normal thyroid function tests were significantly higher at the end of the first and second years of life in this group. Age, TSH and fT4 levels at the time of diagnosis, sex, gestational age, birth weight, symptoms, ultrasonographic and scintigraphic findings, and the state of mental and motor development were similar in the two groups.
T4 dose required to maintain a euthyroid state was the only parameter which distinguished between transient and permanent CH.
关于高促甲状腺素血症患儿临床病程的研究较少。我们旨在评估此类婴儿的临床表现对于预测最终结局的作用。
回顾性分析过去十年中在新生儿期或婴儿早期被诊断为疑似先天性甲状腺功能减退症(CH)的婴儿档案,纳入37例促甲状腺素血症患儿(男/女:20/17),诊断时的中位年龄为3.2个月。纳入标准为:初次新生儿筛查时游离甲状腺素(fT4)水平正常,促甲状腺素(TSH)水平在10 - 20 μIU/mL之间(或之后TSH<10μIU/mL)。将永久性CH患儿(第1组)与暂时性促甲状腺素血症患儿(第2组)在诊断时的年龄、性别、胎龄、出生体重、症状、超声和闪烁扫描结果、初始甲状腺功能检查以及精神和运动发育状况等方面进行比较。
在整个研究组中,20例患儿(54%)最终被诊断为永久性CH。该组在1岁和2岁末维持甲状腺功能检查正常所需的T4剂量显著更高。两组在诊断时的年龄、TSH和fT4水平、性别、胎龄、出生体重、症状、超声和闪烁扫描结果以及精神和运动发育状况相似。
维持甲状腺功能正常状态所需的T4剂量是区分暂时性和永久性CH的唯一参数。